Cargando…

A meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis

BACKGROUND: Meta-analysis of two randomised controlled trials in severe sepsis performed with recombinant human activated protein C may provide further insight as to the therapeutic utility of targeting the clotting cascade in this syndrome. METHODS: In search for relevant studies published, two ran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiedermann, Christian J, Kaneider, Nicole C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266358/ https://www.ncbi.nlm.nih.gov/pubmed/16225672 http://dx.doi.org/10.1186/1471-227X-5-7

Ejemplares similares

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
por: Kaneider, Nicole C., et al.
Publicado: (2007)

Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9
por: Kaneider, Nicole C, et al.
Publicado: (2010)

Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis
por: Shukla, Aparna, et al.
Publicado: (2010)

Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy?
por: Regnault, Veronique, et al.
Publicado: (2007)

Distinct antithrombin III preparations deactivate IL-8-induced neutrophil chemotaxis with different potency
por: Kaneider, N, et al.
Publicado: (2001)

G-protein- and phosphodiesterase-dependent regulation of neutrophil migration by antithrombin III involving CXC-receptor 1
por: Dunzendorfer, S, et al.
Publicado: (2000)

Syndecan-4 on human peripheral blood lymphocytes and monocytes mediates effects of antithrombin on chemotaxis
por: Kaneider, NC, et al.
Publicado: (2002)

Efficacy and effectiveness of recombinant human activated protein C in severe sepsis of adults
por: Schumacher, Helge Knut, et al.
Publicado: (2007)

Updates on role of human recombinant activated protein C in patients with sepsis and severe sepsis: Changed scenario after PROWESS SHOCK trial
por: Shukla, Aparna
Publicado: (2012)

Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study
por: de Pont, Anne-Cornélie JM, et al.
Publicado: (2005)

Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis
por: Wiedermann, Christian J
Publicado: (2008)

Inhibition of proliferation and induction of differentiation of endothelial cells by antithrombin
por: Reinisch, CM, et al.
Publicado: (2002)

Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin
por: Djanani, Angela, et al.
Publicado: (2006)

The limitations of observational studies on the treatment of severe sepsis
por: Wiedermann, Christian J
Publicado: (2002)

Specific deactivation of monocyte and lymphocyte migration by antithrombin III
por: Reinisch, C, et al.
Publicado: (2001)

Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
por: Wiedermann, Christian J
Publicado: (2016)

Clinical review: Molecular mechanisms underlying the role of antithrombin in sepsis
por: Wiedermann, Christian J
Publicado: (2006)

Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center
por: Anger, Kevin E, et al.
Publicado: (2013)

Beautiful small: Misleading large randomized controlled trials? The example of colloids for volume resuscitation
por: Wiedermann, Christian J, et al.
Publicado: (2015)

The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials
por: Liang, Baofang, et al.
Publicado: (2023)

Immunomodulation by α(1)-proteinase inhibitor: lack of chemotactic effects of recombinant human α(1)-proteinase inhibitor from yeast on human peripheral blood granulocytes
por: Mosheimer, Birgit, et al.
Publicado: (2007)

The effect of vitamin C in adults with sepsis: a meta-analysis of randomized controlled trials
por: Luo, Xing, et al.
Publicado: (2023)

Age and number of organ dysfunctions are associated with early mortality in patients suffering from severe sepsis treated with recombinant human activated protein C
por: Vazquez de Anda, G, et al.
Publicado: (2004)

Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy
por: Wiedermann, Christian J.
Publicado: (2022)

Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited
por: Wiedermann, Christian J.
Publicado: (2022)

Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

Use of Hyperoncotic Human Albumin Solution in Severe Traumatic Brain Injury Revisited—A Narrative Review and Meta-Analysis
por: Wiedermann, Christian J.
Publicado: (2022)

Activated protein C in sepsis: an Indian experience
por: Abraham, B, et al.
Publicado: (2005)

Human Albumin Infusion in Critically Ill and Perioperative Patients: Narrative Rapid Review of Meta-Analyses from the Last Five Years
por: Wiedermann, Christian J.
Publicado: (2023)

All that seems sepsis is not sepsis: However, is this case report really a case of catastrophic antiphospholipid syndrome?
por: Stichlberger, Martina, et al.
Publicado: (2014)

Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial
por: Cornet, Alexander D., et al.
Publicado: (2014)

Recombinant human activated protein C for the treatment of severe sepsis and septic shock: a study protocol for incorporating observational evidence using a Bayesian approach
por: Zhang, Zhongheng
Publicado: (2014)

Efficacy and Safety of Recombinant Human Thrombopoietin on Sepsis Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis
por: Zhang, Jin, et al.
Publicado: (2020)

A Network Meta-Analysis of Two Doses of Recombinant Human Thrombopoietin for Treating Sepsis-Related Thrombocytopenia
por: Chen, Dandan, et al.
Publicado: (2022)

Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis
por: Jamdar, Saurabh, et al.
Publicado: (2005)

A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis
por: Tressel, Sarah L, et al.
Publicado: (2011)

Recombinant human activated protein C: current insights into its mechanism of action
por: Levi, Marcel, et al.
Publicado: (2007)

Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis
por: Deckert, Valérie, et al.
Publicado: (2017)

Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies
por: Wiedermann, Christian J., et al.
Publicado: (2010)

Activated protein C in sepsis: down but not out, yet
por: Agarwal, Ritesh, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_vr3a9mmu4dop02klqu3slqgcpe